Journal article
Mechanisms involved in follistatin-induced hypertrophy and increased insulin action in skeletal muscle
X Han, LLV Møller, E De Groote, KN Bojsen-Møller, J Davey, C Henríquez-Olguin, Z Li, JR Knudsen, TE Jensen, S Madsbad, P Gregorevic, EA Richter, L Sylow
Journal of Cachexia Sarcopenia and Muscle | WILEY | Published : 2019
DOI: 10.1002/jcsm.12474
Open access
Abstract
Background: Skeletal muscle wasting is often associated with insulin resistance. A major regulator of muscle mass is the transforming growth factor β (TGF-β) superfamily, including activin A, which causes atrophy. TGF-β superfamily ligands also negatively regulate insulin-sensitive proteins, but whether this pathway contributes to insulin action remains to be determined. Methods: To elucidate if TGF-β superfamily ligands regulate insulin action, we used an adeno-associated virus gene editing approach to overexpress an activin A inhibitor, follistatin (Fst288), in mouse muscle of lean and diet-induced obese mice. We determined basal and insulin-stimulated 2-deoxy-glucose uptake using isotopic..
View full abstractGrants
Awarded by Forskerakademiet
Funding Acknowledgements
The study was supported by several grants. Danish Research Council (grant numbers DFF-4004-00233 to L.S. and DFF-6108-00203A to E.A.R.). The Novo Nordisk Foundation (grant numbers: 27274 to E.A.R. and NNF18OC0032330 to K.N.B.-M.). Novo Nordisk Foundation Excellence project grant to T.E.J. (grant number #15182) and L.S. (grant number #32082). China Scholarship Council (CSC) PhD Scholarship to X.H. and Z.L. PhD scholarship from the National Commission for Scientific and Technological Research (CONICYT) to C.H.-O. PhD fellowship from The Lundbeck Foundation (grant number 2015-3388 to L.L.V.M.).